AdaptHealth Corp. (NASDAQ:AHCO) Receives Consensus Rating of “Moderate Buy” from Analysts

AdaptHealth Corp. (NASDAQ:AHCO) has been given an average recommendation of “Moderate Buy” by the seven analysts that are covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and five have given a buy recommendation to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $13.60.

A number of equities research analysts have recently issued reports on the company. Weiss Ratings lowered AdaptHealth from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday, January 15th. Canaccord Genuity Group boosted their price objective on AdaptHealth from $14.00 to $15.00 and gave the stock a “buy” rating in a research note on Thursday, November 6th. Zacks Research upgraded AdaptHealth from a “strong sell” rating to a “hold” rating in a report on Thursday, January 1st. Finally, Wall Street Zen upgraded AdaptHealth from a “buy” rating to a “strong-buy” rating in a report on Saturday, January 17th.

AdaptHealth Stock Performance

NASDAQ:AHCO opened at $10.05 on Friday. The company’s 50-day moving average price is $10.08 and its 200-day moving average price is $9.55. The company has a current ratio of 1.08, a quick ratio of 0.86 and a debt-to-equity ratio of 1.09. The company has a market cap of $1.36 billion, a P/E ratio of 18.27, a P/E/G ratio of 1.11 and a beta of 1.71. AdaptHealth has a twelve month low of $7.11 and a twelve month high of $11.63.

AdaptHealth (NASDAQ:AHCO) last announced its quarterly earnings data on Tuesday, November 4th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.24 by ($0.05). AdaptHealth had a net margin of 2.53% and a return on equity of 4.85%. The business had revenue of $820.31 million for the quarter, compared to analysts’ expectations of $799.62 million. During the same period in the prior year, the company posted $0.15 EPS. The firm’s revenue was up 1.8% on a year-over-year basis. On average, sell-side analysts forecast that AdaptHealth will post 0.88 earnings per share for the current fiscal year.

Insider Buying and Selling

In other AdaptHealth news, Director David Solomon Williams III sold 5,000 shares of the business’s stock in a transaction dated Thursday, December 4th. The shares were sold at an average price of $9.43, for a total value of $47,150.00. Following the transaction, the director directly owned 45,045 shares in the company, valued at $424,774.35. The trade was a 9.99% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 1.55% of the stock is owned by company insiders.

Institutional Trading of AdaptHealth

Several institutional investors have recently made changes to their positions in AHCO. FNY Investment Advisers LLC acquired a new position in AdaptHealth in the third quarter valued at approximately $35,000. AlphaQuest LLC raised its position in AdaptHealth by 275.7% in the second quarter. AlphaQuest LLC now owns 3,941 shares of the company’s stock valued at $37,000 after purchasing an additional 2,892 shares during the period. Assetmark Inc. raised its position in AdaptHealth by 87.6% in the second quarter. Assetmark Inc. now owns 5,529 shares of the company’s stock valued at $52,000 after purchasing an additional 2,581 shares during the period. Tower Research Capital LLC TRC lifted its stake in shares of AdaptHealth by 318.0% in the 2nd quarter. Tower Research Capital LLC TRC now owns 9,592 shares of the company’s stock valued at $90,000 after purchasing an additional 7,297 shares during the last quarter. Finally, Tidal Investments LLC purchased a new position in shares of AdaptHealth during the 2nd quarter worth $96,000. Hedge funds and other institutional investors own 82.67% of the company’s stock.

AdaptHealth Company Profile

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.